← Leaderboards
Donald A. McClain
W G Hefner Va Medical Center
$44,070,100
Attributed
$45,370,108
Total exposure
36
Grants
34
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.3M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$96,262,676 · 37
VA$0 · 2
By mechanism
UL1$67,834,313 · 17
R01$12,751,262 · 4
P30$8,685,621 · 3
U01$3,690,435 · 1
KL2$1,470,232 · 3
T35$498,473 · 1
Top collaborators
- Carrie L Byington3 shared
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsDiabetes MellitusTranslational ResearchUniversitiesClinical SciencesFundingResearch PersonnelBaseCommunitiesObesityTrainingPhenotypeLinkResearch InfrastructureClinical ResearchClinical TrialsScientistUtahInsulinForestMetabolismTissuesMediatingDiet
Grant awards (124)
Wake Forest Short-term Research Training Program$75,227
T35 · FY2025 · DK · contact PI
North Carolina Diabetes Research Center$1,181,077
P30 · FY2024 · DK · contact PI
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease$658,658
R01 · FY2024 · DK · contact PI
North Carolina Diabetes Research Center$438,648
P30 · FY2024 · DK · contact PI
Wake Forest Short-term Research Training Program$60,812
T35 · FY2024 · DK · contact PI
Mechanism of Integrative Metabolic Regulation by Iron and Hypoxia$0
I01 · FY2024 · VA · contact PI
North Carolina Diabetes Research Center$1,189,284
P30 · FY2023 · DK · contact PI
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease$659,708
R01 · FY2023 · DK · contact PI
North Carolina Diabetes Research Center$444,414
P30 · FY2023 · DK · contact PI
Wake Forest Short-term Research Training Program$59,143
T35 · FY2023 · DK · contact PI
Mechanism of Integrative Metabolic Regulation by Iron and Hypoxia$0
I01 · FY2023 · VA · contact PI
Wake Forest Clinical and Translational Science Award$3,927,951
UL1 · FY2022 · TR · contact PI
North Carolina Diabetes Research Center$1,197,626
P30 · FY2022 · DK · contact PI
North Carolina Diabetes Research Center$450,180
P30 · FY2022 · DK · contact PI
Wake Forest Short-term Research Training Program$68,934
T35 · FY2022 · DK · contact PI
Mechanism of Integrative Metabolic Regulation by Iron and Hypoxia$0
I01 · FY2022 · VA · contact PI
Wake Forest Clinical and Translational Science Award$3,927,951
UL1 · FY2021 · TR · contact PI
North Carolina Diabetes Research Center$1,207,895
P30 · FY2021 · DK · contact PI
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease$667,853
R01 · FY2021 · DK · contact PI
North Carolina Diabetes Research Center$457,930
P30 · FY2021 · DK · contact PI
North Carolina Diabetes Research Center$387,500
P30 · FY2021 · DK · contact PI
Wake Forest Clinical and Translational Science Award$66,270
UL1 · FY2021 · TR · contact PI
Administrative Supplement for Quality Assurance/Quality Control$51,533
UL1 · FY2021 · TR · contact PI
Mechanism of Integrative Metabolic Regulation by Iron and Hypoxia$0
I01 · FY2021 · VA · contact PI
Wake Forest Clinical and Translational Science Award$3,824,885
UL1 · FY2020 · TR · contact PI
North Carolina Diabetes Research Center$1,183,775
P30 · FY2020 · DK · contact PI
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease$655,385
R01 · FY2020 · DK · contact PI
North Carolina Diabetes Research Center$547,292
P30 · FY2020 · DK · contact PI
Wake Forest Clinical and Translational Science Award$123,291
UL1 · FY2020 · TR · contact PI
Wake Forest Short-term Research Training Program$48,189
T35 · FY2020 · DK · contact PI
Wake Forest Clinical and Translational Science Award$3,824,885
UL1 · FY2019 · TR · contact PI
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease$680,226
R01 · FY2019 · DK · contact PI
Wake Forest Short-term Research Training Program$47,810
T35 · FY2019 · DK · contact PI
Wake forest Clinical and Translational Science Award$3,388,470
UL1 · FY2018 · TR · contact PI
Project-003$1,047,546
UL1 · FY2018 · TR · contact PI
Project-004$621,011
UL1 · FY2018 · TR · contact PI
Project-002$546,448
UL1 · FY2018 · TR · contact PI
Admin-Core-001$425,087
UL1 · FY2018 · TR · contact PI
Wake Forest Short-term Research Training Program$42,055
T35 · FY2018 · DK · contact PI
Iron, the circadian clock, and diabetes risk$0
I01 · FY2018 · VA · contact PI
Wake forest Clinical and Translational Science Award$2,610,385
UL1 · FY2017 · TR · contact PI
Iron And Metabolism: Altered Fuel Oxidation And Mitochondrial Dysfunction$447,795
R01 · FY2017 · DK · contact PI
Wake Forest Short-term Research Training Program$49,583
T35 · FY2017 · DK · contact PI
Iron, the circadian clock, and diabetes risk$0
I01 · FY2017 · VA · contact PI
Wake forest Clinical and Translational Science Award$3,365,310
UL1 · FY2016 · TR · contact PI
Iron And Metabolism: Altered Fuel Oxidation And Mitochondrial Dysfunction$447,795
R01 · FY2016 · DK · contact PI
Wake Forest Short-term Research Training Program$46,720
T35 · FY2016 · DK · contact PI
Iron, the circadian clock, and diabetes risk$0
I01 · FY2016 · VA · contact PI
Iron, the circadian clock, and diabetes risk$0
I01 · FY2016 · VA · contact PI
Iron And Metabolism: Altered Fuel Oxidation And Mitochondrial Dysfunction$447,795
R01 · FY2015 · DK · contact PI
Iron, the circadian clock, and diabetes risk$0
I01 · FY2015 · VA · contact PI
Iron And Metabolism: Altered Fuel Oxidation And Mitochondrial Dysfunction$430,461
R01 · FY2014 · DK · contact PI
Iron, Metabolic Regulation and Type 2 Diabetes Risk$0
I01 · FY2014 · VA · contact PI
University of Utah Center for Clinical and Translational Science$2,345,574
UL1 · FY2013 · TR · contact PI
University of Utah Center for Clinical and Translational Science-UL1$1,029,684
UL1 · FY2013 · TR · contact PI
IRON AND METABOLISM: ALTERED FUEL OXIDATION AND MITOCHONDRIAL DYSFUNCTION$397,170
R01 · FY2013 · DK · contact PI
Hexosamines, Glucose Toxicity and Insulin Resistance$298,218
R01 · FY2013 · DK · contact PI
Interdisciplinary Training Program in Metabolism$197,641
T32 · FY2013 · DK · contact PI
University of Utah Center for clinical and Translational Science$141,517
KL2 · FY2013 · TR · contact PI
Iron reduction by phlebotomy for the prevention and treatment of type 2 diabetes$136,193
R21 · FY2013 · DK · contact PI
University of Utah Center for Clinical and Translational Science-KL2$113,715
KL2 · FY2013 · TR · contact PI
University of Utah Center for clinical and Translational Science$112,926
TL1 · FY2013 · TR · contact PI
Interdisciplinary Training Program in Metabolism$57,316
T32 · FY2013 · DK · contact PI
Iron, Metabolic Regulation and Type 2 Diabetes Risk$0
I01 · FY2013 · VA · contact PI
University of Utah Center for Clinical and Translational Science-UL1$4,091,653
UL1 · FY2012 · TR · contact PI
IRON AND METABOLISM: ALTERED FUEL OXIDATION AND MITOCHONDRIAL DYSFUNCTION$412,949
R01 · FY2012 · DK · contact PI
Hexosamines, Glucose Toxicity and Insulin Resistance$310,070
R01 · FY2012 · DK · contact PI
Iron reduction by phlebotomy for the prevention and treatment of type 2 diabetes$278,865
R21 · FY2012 · DK · contact PI
University of Utah Center for Clinical and Translational Science-KL2$243,000
KL2 · FY2012 · TR · contact PI
University of Utah Center for Clinical and Translational Science-TL1$1
TL1 · FY2012 · TR · contact PI
Iron, Metabolic Regulation and Type 2 Diabetes Risk$0
I01 · FY2012 · VA · contact PI
University of Utah Center for Clinical and Translational Science-UL1$4,231,265
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$3,469,637
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$761,628
UL1 · FY2011 · RR · contact PI
IRON AND METABOLISM: ALTERED FUEL OXIDATION AND MITOCHONDRIAL DYSFUNCTION$414,339
R01 · FY2011 · DK · contact PI
Hexosamines, Glucose Toxicity and Insulin Resistance$310,070
R01 · FY2011 · DK · contact PI
University of Utah Center for Clinical and Translational Science-KL2$243,000
KL2 · FY2011 · RR · contact PI
University of Utah Center for Clinical and Translational Science-TL1$1
TL1 · FY2011 · RR · contact PI
Iron, Metabolic Regulation and Type 2 Diabetes Risk$0
I01 · FY2011 · VA · contact PI
University of Utah Center for Clinical and Translational Science-UL1$4,274,005
UL1 · FY2010 · RR · contact PI
UNIVERSITY OF UTAH CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE-UL1$1,709,602
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$1,367,682
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$1,196,721
UL1 · FY2010 · RR · contact PI
IRON AND METABOLISM: ALTERED FUEL OXIDATION AND MITOCHONDRIAL DYSFUNCTION$448,276
R01 · FY2010 · DK · contact PI
Hexosamines, Glucose Toxicity and Insulin Resistance$376,250
R01 · FY2010 · DK · contact PI
University of Utah Center for Clinical and Translational Science-KL2$243,000
KL2 · FY2010 · RR · contact PI
Hexosamines, Glucose Toxicity and Insulin Resistance$103,002
R01 · FY2010 · DK · contact PI
University of Utah Center for Clinical and Translational Science-TL1$1
TL1 · FY2010 · RR · contact PI
University of Utah Center for Clinical and Translational Science-UL1$4,270,700
UL1 · FY2009 · RR · contact PI
UNIVERSITY OF UTAH CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE-UL1$1,622,866
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$1,494,745
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$1,153,089
UL1 · FY2009 · RR · contact PI
University of Utah Center for Clinical and Translational Science-UL1$996,110
UL1 · FY2009 · RR · contact PI
University of Utah Center for Clinical and Translational Science-UL1$985,772
UL1 · FY2009 · RR · contact PI
IRON AND METABOLISM: ALTERED FUEL OXIDATION AND MITOCHONDRIAL DYSFUNCTION$438,577
R01 · FY2009 · DK · contact PI
University of Utah Center for Clinical and Translational Science-UL1$405,929
UL1 · FY2009 · RR · contact PI
UNIVERSITY OF UTAH CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE-UL1: BPCA$405,929
UL1 · FY2009 · RR · contact PI
Hexosamines, Glucose Toxicity and Insulin Resistance$256,303
R01 · FY2009 · DK · contact PI
University of Utah Center for Clinical and Translational Science-KL2$243,000
KL2 · FY2009 · RR · contact PI
University of Utah Center for Clinical and Translational Science-TL1$1
TL1 · FY2009 · RR · contact PI
University of Utah Center for Clinical and Translational Science-UL1$4,270,699
UL1 · FY2008 · RR · contact PI
Hexosamines, Glucose Toxicity and Insulin Resistance$256,303
R01 · FY2008 · DK · contact PI
University of Utah Center for Clinical and Translational Science-KL2$243,000
KL2 · FY2008 · RR · contact PI
University of Utah Center for Clinical and Translational Science-TL1$1
TL1 · FY2008 · RR · contact PI
University of Utah Clinical Research Curriculum Award$300,000
K30 · FY2007 · RR · contact PI
Hexosamines, Glucose Toxicity and Insulin Resistance$261,534
R01 · FY2007 · DK · contact PI
Diabetes in Hemochromatosis: Prevalence and Mechanisms$245,026
R56 · FY2007 · DK · contact PI
DIABETES IN HEMOCHROMATOSIS: PREVALENCE AND MECHANISMS$344,217
R01 · FY2006 · DK · contact PI
Hexosamines, Glucose Toxicity and Insulin Resistance$269,345
R01 · FY2006 · DK · contact PI
ANIMAL MODELS OF DIABETIC CARDIOVASCULAR COMPLICATIONS$736,888
U01 · FY2005 · HL
DIABETES IN HEMOCHROMATOSIS: PREVALENCE AND MECHANISMS$352,500
R01 · FY2005 · DK
Hexosamines, Glucose Toxicity and Insulin Resistance$275,828
R01 · FY2005 · DK
ANIMAL MODELS OF DIABETIC CARDIOVASCULAR COMPLICATIONS$736,888
U01 · FY2004 · HL
DIABETES IN HEMOCHROMATOSIS: PREVALENCE AND MECHANISMS$352,500
R01 · FY2004 · DK
Non-invasive blood glucose monitoring$4,368
M01 · FY2004 · RR
ANIMAL MODELS OF DIABETIC CARDIOVASCULAR COMPLICATIONS$732,688
U01 · FY2003 · HL
DIABETES IN HEMOCHROMATOSIS: PREVALENCE AND MECHANISMS$352,500
R01 · FY2003 · DK
HEXOSAMINES, GLUCOSE TOXICITY AND INSULIN RESISTANCE$262,500
R01 · FY2003 · DK
ANIMAL MODELS OF DIABETIC CARDIOVASCULAR COMPLICATIONS$736,888
U01 · FY2002 · HL
DIABETES IN HEMOCHROMATOSIS: PREVALENCE AND MECHANISMS$352,500
R01 · FY2002 · DK
HEXOSAMINES, GLUCOSE TOXICITY AND INSULIN RESISTANCE$262,500
R01 · FY2002 · DK
ANIMAL MODELS OF DIABETIC CARDIOVASCULAR COMPLICATIONS$747,083
U01 · FY2001 · HL
HEXOSAMINES, GLUCOSE TOXICITY AND INSULIN RESISTANCE$262,500
R01 · FY2001 · DK
HEXOSAMINES, GLUCOSE TOXICITY AND INSULIN RESISTANCE$285,635
R01 · FY2000 · DK